The Effects of a Multi-ingredient Supplement on Markers of Muscle Damage and Inflammation Following Downhill Running in Females
Overview
Affiliations
Background: The effects of a multi-ingredient performance supplement (MIPS) on markers of inflammation and muscle damage, perceived soreness and lower limb performance are unknown in endurance-trained female athletes. The purpose of this study was to determine the impact of MIPS (NO-Shotgun®) pre-loaded 4 weeks prior to a single-bout of downhill running (DHR) on hsC-Reactive Protein (hsCRP), interleukin (IL)-6, creatine kinase (CK), muscle soreness, lower limb circumferences and performance.
Method: Trained female runners ( = 8; 29 ± 5.9 years) (VO: ≥ 50 ml.kg.min, midfollicular phase (7-11 days post-menses) were randomly assigned in a double-blind manner into two groups: MIPS ( = 4) ingested one serving of NO Shotgun daily for 28 days prior to DHR and 30 min prior to all post-testing visits; Control (CON) ( = 4) consumed an isocaloric maltodextrin placebo in an identical manner to MIPS. hsCRP, IL-6, CK, perceived soreness, limb circumferences, and performance measures (flexibility, squat jump peak power) were tested on 5 occasions; immediately before (PRE), immediately post-DHR, 24, 48 and 72 h post-DHR.
Results: There were main effects of time for CK ( = 0.05), pain pressure threshold (right tibialis anterior ( = 0.010), right biceps femoris ( = 0.01), and left iliotibial band (ITB) ( = 0.05) across all time points), and maximum squat jump power ( = 0.04). Compared with 24 h post-DHR, maximum squat jump power was significantly lower at 48 h post-DHR ( = 0.05). Lower body perceived soreness was significantly increased at 24 h ( = 0.02) and baseline to 48 h ( = 0.02) post DHR. IL-6 peaked immediately post-DHR ( = 0.03) and hsCRP peaked at 24 h post-DHR ( = 0.06). Calculation of effect sizes indicated a moderate attenuation of hsCRP in MIPS at 72 h post-DHR.
Conclusions: Consumption of MIPS for 4 weeks prior to a single bout of DHR attenuated inflammation three days post, but did not affect perceived soreness and muscle damage markers in endurance trained female runners following a single bout of DHR.
Collier-Bain H, Brown F, Causer A, Ross L, Rothschild-Rodriguez D, Browne N Sci Rep. 2024; 14(1):28239.
PMID: 39548231 PMC: 11568217. DOI: 10.1038/s41598-024-79690-8.
Larrosa M, Gil-Izquierdo A, Gonzalez-Rodriguez L, Alferez M, San Juan A, Sanchez-Gomez A Nutr Rev. 2024; 83(3):e1068-e1089.
PMID: 38994896 PMC: 11819490. DOI: 10.1093/nutrit/nuae082.
Tallis J, McMorrow C, Shelley S, Eustace S Sports (Basel). 2024; 12(6).
PMID: 38921863 PMC: 11209549. DOI: 10.3390/sports12060169.
Douligeris A, Methenitis S, Stavropoulos-Kalinoglou A, Panayiotou G, Vogazianos P, Lazou A J Funct Morphol Kinesiol. 2024; 9(2).
PMID: 38804451 PMC: 11130865. DOI: 10.3390/jfmk9020085.
Rohling M, McCarthy D, Berg A Nutrients. 2021; 13(9).
PMID: 34578807 PMC: 8472015. DOI: 10.3390/nu13092929.